Literature DB >> 23061943

Outcomes of open carpal tunnel releases and its predictors: a prospective study.

Jacqueline Siau Woon Tan1, Agnes Beng-Hoi Tan.   

Abstract

A prospective study of 74 patients who underwent open carpal tunnel releases was conducted, with a follow-up period of six months. We analyzed multiple preoperative variables in order to identify factors that might predict outcomes. These outcomes included improvement in symptom severity and functional severity scores, grip strength as well as patient satisfaction. All the patients showed improvement in symptoms with 72% showing complete symptomatic relief, 74% showing improvement in function and 66% showing improvement in grip strength, and 82% were either completely or very satisfied with the results of surgery. Older patients and patients with weakness were associated with poorer outcomes. Higher preoperative symptom severity and functional severity scores were also associated with less improvement in symptoms and function, respectively. This information would benefit the surgeons and patients during preoperative counseling and help facilitate the decision-making process for both parties.

Entities:  

Mesh:

Year:  2012        PMID: 23061943     DOI: 10.1142/S0218810412500281

Source DB:  PubMed          Journal:  Hand Surg        ISSN: 0218-8104


  3 in total

1.  Corticoid injection as a predictive factor of results of carpal tunnel release.

Authors:  Giselly Veríssimo de Miranda; Carlos Henrique Fernandes; Jorge Raduan; Lia Miyamoto Meirelles; João Baptista Gomes Dos Santos; Flávio Faloppa
Journal:  Acta Ortop Bras       Date:  2015 Mar-Apr       Impact factor: 0.513

Review 2.  Grip Strength Measurement for Outcome Assessment in Common Hand Surgeries.

Authors:  Seung Hoo Lee; Hyun Sik Gong
Journal:  Clin Orthop Surg       Date:  2022-02-03

3.  Higher preoperative pain catastrophizing increases the risk of low patient reported satisfaction after carpal tunnel release: a prospective study.

Authors:  Sebastian Breddam Mosegaard; Maiken Stilling; Torben Bæk Hansen
Journal:  BMC Musculoskelet Disord       Date:  2020-01-18       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.